Clinical Trial

Pain Management Study

Enrolling by Invitation Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated August 24, 2025 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aims to better understand the role that narcotic vs. non-narcotic multimodal pain management play in patients' pain following bariatric surgery (Laproscopic Surgery and Robotic Assisted Surgery). Participation in this study will last approximately 90 days following surgery. During that 90 day period, participants will be asked to report pain and nausea every 4 hours to a study coordinator or nurse while they are recovering in the hospital. Following discharge from the hospital patients will be asked to report pain, nausea, and any medical changes 7 days, 30 days, and 90 days from surgical date. The procedures and medications used in this study are FDA approved medical therapies and are part of Standard of Care for this population. This study aims to therapeutically investigate efficacy of the proposed pain management regimens. The procedures and individual medications are not the subject of research as they are considered routine well established and documented interventions for obesity and the treatment of post operative pain.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2022-01-27; most recent amendment 2025-08-18.
Status change: Recruiting → Enrolling by Invitation 2024-02-15
Trial Details
NCT Number NCT05231460
Lead Sponsor University of Arizona
Conditions Pain, Postoperative
Enrollment 244 participants
Start Date 2022-02-18
Primary Completion 2026-06 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2025-08-24